SynthesisFrontiers in endocrinology2025
Horner syndrome as a postoperative complication of thyroid surgery: a systematic review.
Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This systematic review aims to enhance surgeons' awareness of Horner Syndrome (HS) as a rare yet significant complication following thyroid surgery (TS). Data sources: Web of Science, PubMed, Cochrane Library, and Embase. Review methods: Based on the PRISMA framework, a comprehensive literature search was conducted covering the period from January 1, 2000, to June 1, 2025. Results: Out of the 308 articles retrieved, 50 were included in this review, comprising 14 case series and 36 case reports. These studies documented a total of 40 cases of HS following TS. The overall incidence of HS was found to be 0.25%, with a higher incidence in open surgery (0.41%) compared to endoscopic surgery (0.15%). The incidence rate among children undergoing open surgery was 1.84%, which was higher than that among adults (0.22%). Malignant cases accounted for 67.5%, while benign cases represented the remaining 32.5%. HS symptoms typically manifested within 3 days post-surgery, with ptosis being the most common presentation. It rarely affects ocular function but may lead to decreased vision or heterochromia. Short-term steroid and neurotrophic therapy demonstrated some efficacy in alleviating symptoms, and complete recovery was more likely to occur within one year. Conclusion: HS represents a rare yet significant complication of TS, primarily attributed to surgical trauma to the cervical sympathetic chain (CSC). Clinicians must remain vigilant regarding this complication and employ meticulous surgical techniques to prevent CSC injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.